Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AGfiledCriticalSchering AG
Priority to DESCH3349DpriorityCriticalpatent/DE870404C/de
Priority to DK60176Dprioritypatent/DK60176C/da
Application grantedgrantedCritical
Publication of DE870404CpublicationCriticalpatent/DE870404C/de
C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
Health & Medical Sciences
(AREA)
General Health & Medical Sciences
(AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof
(AREA)
Steroid Compounds
(AREA)
DESCH3349D1938-12-071938-12-07Verfahren zur Darstellung von Ketolen der Cyclopentanopolyhydrophenanthrenreihe
ExpiredDE870404C
(de)